Toronto Dominion Bank
DYN icon

Toronto Dominion Bank’s Dyne Therapeutics DYN Stock Holding History

Toronto Dominion Bank’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3
Closed – – 1459
2022
Q1 		$0 Hold
3
– – ﹤0.01% 1557
2021
Q4 		$0 Buy
+3
New +$42 ﹤0.01% 1618

Other funds holding DYN

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Toronto Dominion Bank's DYN Position: Q2 2022 in Review

Toronto Dominion Bank sold out of Dyne Therapeutics (DYN) in Q2 2022, closing a stake of 3 shares.

Toronto Dominion Bank first reported a position in DYN in Q4 2021 and held it in 2 quarters. The position peaked at $0 in Q1 2022. 90 funds tracked by Wall St. Rank hold DYN as of Q2 2022.

  • Toronto Dominion Bank reported no remaining Dyne Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Toronto Dominion Bank sold 3 Dyne Therapeutics shares in Q2 2022.
  • Toronto Dominion Bank first reported a position in Dyne Therapeutics in Q4 2021 and held it in 2 quarters.
  • Toronto Dominion Bank's Dyne Therapeutics position peaked at $0 in Q1 2022.
  • 90 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2022.

Based on Toronto Dominion Bank's 13F filing for Q2 2022, filed 11 Aug 2022.